Scholarlink

<p>Metabolic dysfunction-associated steatohepatitis (MASH) is characterized by lipid accumulation and inflammatory injury. Kupffer cells (KC) play a key role in the immune response and metabolic homeostasis in the liver. We evaluated the impact of hemin treatment on the phenotype of KC and on metabolism and mitochondrial dynamics of hepatocytes in a rat model of early-stage MASH induced by a high-carbohydrate diet. In the liver, HO-1 induction by hemin was associated with reduced tissue injury and apoptosis, restored oxidative balance, attenuated UPR activation, reinstated autophagic flux and improved mitochondrial dynamics. In addition, hemin treatment enhanced fatty acid oxidation and insulin sensitivity in a KC-independent manner. These results suggest that hemin treatment exerts hepatoprotective effects in a rat model of early-stage MASH, highlighting the potential of this treatment as a therapeutic approach for MASH.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Heme oxygenase-1 induction by hemin: a novel approach to enhance mitochondrial turnover and mitigate diet-induced liver damage

  • 期刊论文

  • 发表日期：

    2026年4月30日

查看全文
  • Morena Wiszniewski,
  • Lilian J. Caldareri,
  • Diego Mori,
  • Federico Jara,
  • Cora B. Cymeryng,
  • Esteban M. Repetto

摘要

Metabolic dysfunction-associated steatohepatitis (MASH) is characterized by lipid accumulation and inflammatory injury. Kupffer cells (KC) play a key role in the immune response and metabolic homeostasis in the liver. We evaluated the impact of hemin treatment on the phenotype of KC and on metabolism and mitochondrial dynamics of hepatocytes in a rat model of early-stage MASH induced by a high-carbohydrate diet. In the liver, HO-1 induction by hemin was associated with reduced tissue injury and apoptosis, restored oxidative balance, attenuated UPR activation, reinstated autophagic flux and improved mitochondrial dynamics. In addition, hemin treatment enhanced fatty acid oxidation and insulin sensitivity in a KC-independent manner. These results suggest that hemin treatment exerts hepatoprotective effects in a rat model of early-stage MASH, highlighting the potential of this treatment as a therapeutic approach for MASH.